Dana Gebhart

Title: Dana Gebhart: Innovator in Bacteriocin Research

Introduction

Dana Gebhart is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of bacteriocin research, holding a total of 5 patents. Her work focuses on the identification and engineering of enterocins, which are crucial for developing new antimicrobial agents.

Latest Patents

Dana's latest patents include groundbreaking innovations such as "Enterocins and methods of using the same." This patent discusses the identification, cloning, and expression of a genetic locus that encodes a phage tail-like bacteriocin, termed an enterocin. The patent also covers non-natural enterocins engineered for altered bactericidal specificity, along with methods for their production and application. Another notable patent is related to "Insertable variable fragments of antibodies and modified α1-α2 domains of NKG2D ligands." This application focuses on producing polypeptides with specific antigen-binding properties, including modified domains attached to antibodies.

Career Highlights

Throughout her career, Dana has worked with notable companies such as Xyphos Biosciences Inc. and Avidbiotics Corporation. Her innovative research has positioned her as a leader in her field, contributing to advancements in biotechnology and therapeutic applications.

Collaborations

Dana has collaborated with esteemed colleagues, including Dean M Scholl and Kyle Landgraf. These partnerships have further enhanced her research and development efforts in bacteriocin technology.

Conclusion

Dana Gebhart's contributions to bacteriocin research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for new antimicrobial solutions and advancements in biotechnology.